Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer

Virchows Archiv

Volumn 453, Issue 6, 2008, Pages 545-555

  Fujii, Takuma ^a   Saito, Miyuki ^a   Iwata, Takashi ^a   Hirao, Nobumaru ^a   Nishio, Hiroshi ^a   Ohno, Akiko ^a   Tsukazaki, Katsumi ^a   Mukai, Makio ^a   Kameyama, Kaori ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cervical cancer screening; Human papillomavirus; In situ hybridization; Integration; Liquid based cytology; P16

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 55849146643     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-008-0687-5     Document Type: Article

References (52)

1. DM Parkin F Bray 2006 Chapter 2: the burden of HPV-related cancers Vaccine 24 Suppl 3 S11 S25
2. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Munoz 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12 19
3. H zur Hausen 1991 Viruses in human cancers Science 254 1167 1173
4. H zur Hausen 2002 Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 342 350
5. M Scheffner U Nuber JM Huibregtse 1995 Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade Nature 373 81 83
6. S Duensing A Duensing ER Flores A Do PF Lambert K Munger 2001 Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes J Virol 75 7712 7716
7. S Jeon BL Allen-Hoffmann PF Lambert 1995 Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells J Virol 69 2989 2997
8. M Serrano GJ Hannon D Beach 1993 A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 704 707
9. Y Li MA Nichols JW Shay Y Xiong 1994 Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb Cancer Res 54 6078 6082
10. F Bringold M Serrano 2000 Tumor suppressors and oncogenes in cellular senescence Exp Gerontol 35 317 329
11. E Hara R Smith D Parry H Tahara S Stone G Peters 1996 Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence Mol Cell Biol 16 859 867
12. M Serrano AW Lin ME McCurrach D Beach SW Lowe 1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 88 593 602
13. N Ohtani Z Zebedee TJ Huot JA Stinson M Sugimoto Y Ohashi AD Sharrocks G Peters E Hara 2001 Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence Nature 409 1067 1070
14. D Parry S Bates DJ Mann G Peters 1995 Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product EMBO J 14 503 511
15. M Sakaguchi Y Fujii H Hirabayashi HE Yoon Y Komoto T Oue T Kusafuka A Okada H Matsuda 1996 Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study Int J Cancer 65 442 445
16. SN Khleif J DeGregori CL Yee GA Otterson FJ Kaye JR Nevins PM Howley 1996 Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity Proc Natl Acad Sci U S A 93 4350 4354
17. T Sano T Oyama K Kashiwabara T Fukuda T Nakajima 1998 Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia Pathol Int 48 580 585
18. M Ishikawa T Fujii N Masumoto M Saito M Mukai I Nindl R Ridder T Fukuchi K Kubushiro K Tsukazaki S Nozawa 2003 Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas Int J Gynecol Pathol 22 378 385
19. M Ishikawa T Fujii M Saito I Nindl A Ono K Kubushiro K Tsukazaki M Mukai S Nozawa 2006 Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia Int J Gynecol Cancer 16 347 353
20. N Masumoto T Fujii M Ishikawa M Saito T Iwata T Fukuchi N Susumu M Mukai K Kubushiro K Tsukazaki S Nozawa 2003 P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix Hum Pathol 34 778 783
21. T Sano T Hikino Q Xue T Saito K Kashiwabara T Oyama T Nakajima 2000 Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma Pathol Int 50 709 716
22. T Sano T Oyama K Kashiwabara T Fukuda T Nakajima 1998 Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am J of Pathol 153 1741 1748
23. JT Keating A Cviko S Riethdorf L Riethdorf BJ Quade D Sun S Duensing EE Sheets K Munger CP Crum 2001 Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia Am J Surg Pathol 25 884 891
24. R Klaes T Friedrich D Spitkovsky R Ridder W Rudy U Petry G Dallenbach-Hellweg D Schmidt M von Knebel Doeberitz 2001 Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int J Cancer 92 276 284
25. G Lizard MJ Demares-Poulet P Roignot P Gambert 2001 In situ hybridization detection of single-copy human papillomavirus on isolated cells, using a catalyzed signal amplification system: GenPoint Diagn Cytopathol 24 112 116
26. F Alameda L Pijuan L Ferrer ML Marinoso M Muset I Soler E Gimferrer S Serrano 2005 Human papilloma virus detection in liquid cytology, in situ hybridization and polymerase chain reaction Virchows Arch 446 202 203
27. M Guo SJ Patel M Chovanec YJ Jan E Tarco TB Bevers K Anderson N Sneige 2007 A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies Acta Cytol 51 749 754
28. C Bewtra Q Xie S Soundararajan Z Gatalica L Hatcher 2005 Genital human papillomavirus testing by in situ hybridization in liquid atypical cytologic materials and follow-up biopsies Acta Cytol 49 127 131
29. MJ Trunk G Dallenbach-Hellweg R Ridder KU Petry H Ikenberg V Schneider M von Knebel Doeberitz 2004 Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples Acta Cytol 48 771 782
30. S Bose H Evans L Lantzy K Scharre E Youssef 2005 p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear Diagn Cytopathol 32 21 24
31. T Yoshida T Fukuda T Sano T Kanuma N Owada T Nakajima 2004 Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials Cancer 102 100 108
32. A Saqi TL Pasha CM McGrath GH Yu P Zhang P Gupta 2002 Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia Diagn Cytopathol 27 365 370
33. N Wentzensen C Bergeron F Cas D Eschenbach S Vinokurova M von Knebel Doeberitz 2005 Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples Cancer 105 461 467
34. S Sahebali CE Depuydt GA Boulet M Arbyn LM Moeneclaey AJ Vereecken EA Van Marck JJ Bogers 2006 Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study Int J Cancer 118 1254 1260
35. M Bibbo WJ Klump J DeCecco AJ Kovatich 2002 Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens Acta Cytol 46 25 29
36. C Pientong T Ekalaksananan U Swadpanich B Kongyingyoes O Kritpetcharat P Yuenyao N Ruckait 2003 Immunocytochemical detection of p16INK4a protein in scraped cervical cells Acta Cytol 47 616 623
37. J Monsonego G Pollini MJ Evrard P Sednaoui L Monfort D Quinzat R Dachez K Syrjanen 2007 P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear Acta Cytol 51 755 766
38. VB Carydis T Walker A Wing TJ Colgan 2007 Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions Acta Cytol 51 517 522
39. S Nieh SF Chen TY Chu HC Lai E Fu 2004 Expression of p16INK4A in Pap smears containing atypical glandular cells from the uterine cervix Acta Cytol 48 173 180
40. AG Ostor 1993 Natural history of cervical intraepithelial neoplasia: a critical review Int J Gynecol Pathol 12 186 192
41. D Solomon D Davey R Kurman A Moriarty D O'Connor M Prey S Raab M Sherman D Wilbur T Wright Jr. N Young 2002 The 2001 Bethesda System: terminology for reporting results of cervical cytology Jama 287 2114 2119
42. H Yoshikawa T Kawana K Kitagawa M Mizuno H Yoshikura A Iwamoto 1991 Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers Jpn J Cancer Res 82 524 531
43. N Masumoto T Fujii M Ishikawa M Mukai M Saito T Iwata T Fukuchi K Kubushiro K Tsukazaki S Nozawa 2003 Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women Br J Cancer 88 1883 1888
44. AH Hopman MA Kamps F Smedts EJ Speel CS Herrington FC Ramaekers 2005 HPV in situ hybridization: impact of different protocols on the detection of integrated HPV Int J Cancer 115 419 428
45. K Cooper CS Herrington JE Stickland MF Evans JO McGee 1991 Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation J Clin Pathol 44 990 996
46. EM de Villiers C Fauquet TR Broker HU Bernard H zur Hausen 2004 Classification of papillomaviruses Virology 324 17 27
47. T Matsukura S Koi M Sugase 1989 Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers Virology 172 63 72
48. M Durst A Kleinheinz M Hotz L Gissman 1985 The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours J Gen Virol 66 1515 1522
49. P Peitsaro B Johansson S Syrjanen 2002 Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique J Clin Microbiol 40 886 891
50. T Fujii N Masumoto M Saito N Hirao S Niimi M Mukai A Ono S Hayashi K Kubushiro E Sakai K Tsukazaki S Nozawa 2005 Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia Diagn Mol Pathol 14 103 108
51. A Algeciras-Schimnich F Policht S Sitailo M Song L Morrison I Sokolova 2007 Evaluation of quantity and staining pattern of human papillomavirus (HPV)-infected epithelial cells in thin-layer cervical specimens using optimized HPV-CARD assay Cancer 111 330 338
52. CL Schiller AG Nickolov KL Kaul EA Hahn JM Hy MT Escobar WG Watkin CD Sturgis 2004 High-risk human papillomavirus detection: a split-sample comparison of hybrid capture and chromogenic in situ hybridization Am J Clin Pathol 121 537 545